Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janbernd Kirschner

Showing results (11-20 of 173) with videos related to

Pageof 18
Sort By:
Neuropediatrics|August 14, 2019
Decision-Making Regarding Ventilator Support in Children with SMA Type 1-A Cross-Sectional Survey among PhysiciansAstrid Pechmann, Thorsten Langer, Janbernd Kirschner
JAMA Pediatrics|July 29, 2024
Concerns About Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy-ReplyOliver Schwartz, Astrid Pechmann, Janbernd Kirschner
Neuropediatrics|February 23, 2022
Parents' Perspectives on Diagnosis and Decision-Making regarding Ventilator Support in Children with SMA Type 1Astrid Pechmann, Thorsten Langer, Janbernd Kirschner
Journal of Neuromuscular Diseases|November 11, 2019
Advances in Treatment of Spinal Muscular Atrophy - New Phenotypes, New Challenges, New Implications for CareDavid C Schorling, Astrid Pechmann, Janbernd Kirschner
Neuropediatrics|July 3, 2017
Congenital Muscular Dystrophies and Myopathies: An Overview and UpdateDavid C Schorling, Janbernd Kirschner, Carsten G Bönnemann
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|December 7, 2017
Single-center experience with intrathecal administration of Nusinersen in children with spinal muscular atrophy type 1Astrid Pechmann, Thorsten Langer, Sabine Wider, et al.
Orphanet Journal of Rare Diseases|July 31, 2020
Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative studyPetra Kiefer, Janbernd Kirschner, Astrid Pechmann, et al.
Pediatrics|July 5, 2005
Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barré syndrome: a randomized trialRudolf Korinthenberg, Joachim Schessl, Janbernd Kirschner, et al.
Joint Bone Spine|June 16, 2009
Muscle hypertrophy of the lower leg caused by L5 radiculopathyMichael Kottlors, Klaus Mueller, Janbernd Kirschner, et al.
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|June 5, 2012
Drug treatment of Duchenne muscular dystrophy: available evidence and perspectivesMaria de los Angeles Beytía, Julia Vry, Janbernd Kirschner
Pageof 18

Showing results (11-20 of 173) with videos related to

Sort By:
Pageof 18
Neuropediatrics|August 14, 2019
Decision-Making Regarding Ventilator Support in Children with SMA Type 1-A Cross-Sectional Survey among PhysiciansAstrid Pechmann, Thorsten Langer, Janbernd Kirschner
JAMA Pediatrics|July 29, 2024
Concerns About Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy-ReplyOliver Schwartz, Astrid Pechmann, Janbernd Kirschner
Neuropediatrics|February 23, 2022
Parents' Perspectives on Diagnosis and Decision-Making regarding Ventilator Support in Children with SMA Type 1Astrid Pechmann, Thorsten Langer, Janbernd Kirschner
Journal of Neuromuscular Diseases|November 11, 2019
Advances in Treatment of Spinal Muscular Atrophy - New Phenotypes, New Challenges, New Implications for CareDavid C Schorling, Astrid Pechmann, Janbernd Kirschner
Neuropediatrics|July 3, 2017
Congenital Muscular Dystrophies and Myopathies: An Overview and UpdateDavid C Schorling, Janbernd Kirschner, Carsten G Bönnemann
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|December 7, 2017
Single-center experience with intrathecal administration of Nusinersen in children with spinal muscular atrophy type 1Astrid Pechmann, Thorsten Langer, Sabine Wider, et al.
Orphanet Journal of Rare Diseases|July 31, 2020
Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative studyPetra Kiefer, Janbernd Kirschner, Astrid Pechmann, et al.
Pediatrics|July 5, 2005
Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barré syndrome: a randomized trialRudolf Korinthenberg, Joachim Schessl, Janbernd Kirschner, et al.
Joint Bone Spine|June 16, 2009
Muscle hypertrophy of the lower leg caused by L5 radiculopathyMichael Kottlors, Klaus Mueller, Janbernd Kirschner, et al.
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|June 5, 2012
Drug treatment of Duchenne muscular dystrophy: available evidence and perspectivesMaria de los Angeles Beytía, Julia Vry, Janbernd Kirschner
Pageof 18